ERBB2 and breast carcinoma: Similarly, overexpression of HER2 (Human epidermal growth factor receptor-2) in breast cancer cells is closely related to the proliferation of neoplastic cells and the progression of the carcinogenesis process, and its pro-carcinogenic effect results from the intensification of inflammation and increased expansion of tumor stem cells (CSCs) [11,12].